These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 7323120

  • 1. Sleep suppressant action of quipazine: relation to central serotonergic stimulation.
    Fornal C, Radulovacki M.
    Pharmacol Biochem Behav; 1981 Dec; 15(6):937-44. PubMed ID: 7323120
    [Abstract] [Full Text] [Related]

  • 2. Quipazine has a biphasic effect on slow wave sleep and reduces REM sleep rebound in REM sleep deprived rats.
    Zak R, Radulovacki M.
    Brain Res Bull; 1982 Mar; 8(3):329-31. PubMed ID: 7093740
    [Abstract] [Full Text] [Related]

  • 3. Methysergide blocks the sleep suppressant action of quipazine in rats.
    Fornal C, Radulovacki M.
    Psychopharmacology (Berl); 1982 Mar; 76(3):255-9. PubMed ID: 6808546
    [Abstract] [Full Text] [Related]

  • 4. Sleep suppressant action of fenfluramine in rats. I. Relation to postsynaptic serotonergic stimulation.
    Fornal C, Radulovacki M.
    J Pharmacol Exp Ther; 1983 Jun; 225(3):667-74. PubMed ID: 6683311
    [Abstract] [Full Text] [Related]

  • 5. Sleep suppressant action of fenfluramine in rats. II. Evidence against the involvement of presynaptic serotonergic mechanism.
    Fornal C, Radulovacki M.
    J Pharmacol Exp Ther; 1983 Jun; 225(3):675-81. PubMed ID: 6223135
    [Abstract] [Full Text] [Related]

  • 6. Increased waking as well as increased synchronization following administration of selective 5-HT uptake inhibitors to rats.
    Ursin R, Bjorvatn B, Sommerfelt L, Underland G.
    Behav Brain Res; 1989 Aug 01; 34(1-2):117-30. PubMed ID: 2527519
    [Abstract] [Full Text] [Related]

  • 7. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
    Eison AS, Eison MS, Yocca FD, Gianutsos G.
    Life Sci; 1989 Aug 01; 44(19):1419-27. PubMed ID: 2785627
    [Abstract] [Full Text] [Related]

  • 8. Serotonin control of sleep-wake behavior.
    Monti JM.
    Sleep Med Rev; 2011 Aug 01; 15(4):269-81. PubMed ID: 21459634
    [Abstract] [Full Text] [Related]

  • 9. Effect of p-chlorophenylalanine and tryptophan on sleep, EEG and motor activity in the rat.
    Borbély AA, Neuhaus HU, Tobler I.
    Behav Brain Res; 1981 Jan 01; 2(1):1-22. PubMed ID: 6452888
    [Abstract] [Full Text] [Related]

  • 10. Effects of the 5-HT₆ receptor antagonists SB-399885 and RO-4368554 and of the 5-HT(2A) receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light-dark cycle.
    Monti JM, Jantos H.
    Behav Brain Res; 2011 Jan 01; 216(1):381-8. PubMed ID: 20732355
    [Abstract] [Full Text] [Related]

  • 11. Effects of zimeldine, a selective 5-HT reuptake inhibitor, combined with ritanserin, a selective 5-HT2 antagonist, on waking and sleep stages in rats.
    Bjorvatn B, Ursin R.
    Behav Brain Res; 1990 Nov 30; 40(3):239-46. PubMed ID: 2149499
    [Abstract] [Full Text] [Related]

  • 12. Effects of metergoline and quipazine on locomotor activity of rats in novel and familiar environments.
    Beninger RJ.
    Pharmacol Biochem Behav; 1984 May 30; 20(5):701-5. PubMed ID: 6739514
    [Abstract] [Full Text] [Related]

  • 13. Serotonin and the mammalian circadian system: I. In vitro phase shifts by serotonergic agonists and antagonists.
    Prosser RA, Dean RR, Edgar DM, Heller HC, Miller JD.
    J Biol Rhythms; 1993 May 30; 8(1):1-16. PubMed ID: 8490207
    [Abstract] [Full Text] [Related]

  • 14. Serotonin-induced head shaking behavior in rats does not involve receptors located in the frontal cortex.
    Lucki I, Minugh-Purvis N.
    Brain Res; 1987 Sep 15; 420(2):403-6. PubMed ID: 2960422
    [Abstract] [Full Text] [Related]

  • 15. Effects of selective activation of the 5-HT1B receptor with CP-94,253 on sleep and wakefulness in the rat.
    Monti JM, Monti D, Jantos H, Ponzoni A.
    Neuropharmacology; 1995 Dec 15; 34(12):1647-51. PubMed ID: 8788962
    [Abstract] [Full Text] [Related]

  • 16. Effect of pharmacologic treatments on the sleep of depressed patients.
    Sharpley AL, Cowen PJ.
    Biol Psychiatry; 1995 Jan 15; 37(2):85-98. PubMed ID: 7718684
    [Abstract] [Full Text] [Related]

  • 17. The response of suprachiasmatic neurons of the rat hypothalamus to photic and serotonergic stimulation.
    Miller JD, Fuller CA.
    Brain Res; 1990 May 07; 515(1-2):155-62. PubMed ID: 2357553
    [Abstract] [Full Text] [Related]

  • 18. Suppressant effects of selective 5-HT2 antagonists on rapid eye movement sleep in rats.
    Tortella FC, Echevarria E, Pastel RH, Cox B, Blackburn TP.
    Brain Res; 1989 Apr 24; 485(2):294-300. PubMed ID: 2720415
    [Abstract] [Full Text] [Related]

  • 19. Sleep/waking and EEG power spectrum effects of a nonselective serotonin (5-HT) antagonist and a selective 5-HT reuptake inhibitor given alone and in combination.
    Bjorvatn B, Bjørkum AA, Neckelmann D, Ursin R.
    Sleep; 1995 Jul 24; 18(6):451-62. PubMed ID: 7481417
    [Abstract] [Full Text] [Related]

  • 20. Reduced head-twitch response to quipazine of rats previously treated with methiothepin: possible involvement of dopaminergic system.
    Dall'Olio R, Vaccheri A, Montanaro N.
    Pharmacol Biochem Behav; 1985 Jul 24; 23(1):43-8. PubMed ID: 2994121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.